Aier Eye Hospital: Company Continues to Advance "1+8+N" Strategy, 9 Flagship Hospitals Have Been Essentially Completed and Put into Operation

Securities Daily, March 18 — When asked by researchers, Aier Eye Hospital stated that over the past few years, the company has been continuously advancing its “1+8+N” strategy. Based on achieving global scale leadership, it focuses on building one world-class ophthalmology hospital and eight national regional eye centers, strengthening the leading hospitals to drive overall development. Currently, these nine flagship hospitals have been largely completed and put into operation. The company has entered a new stage of “upgrading,” with improved technology, enhanced services, and increased brand influence. The ceiling for older hospitals has also been significantly raised. In the future, the company will focus on high-quality development, continuously improve management levels, and promote progress in three key areas: refining domestic operations, expanding overseas markets, and leveraging advanced technology.

Refining domestic operations involves enhancing management efficiency, medical quality, talent development, and service capabilities to solidify the foundation for growth. Meanwhile, the company has launched a “three-year breakthrough” plan, leveraging the leading hospitals to further expand growth potential, turn around and increase profits for emerging hospitals, and strengthen service connections with patients. The ecological layout will achieve greater progress, laying a solid foundation for sustainable development under the new normal.

Expanding and strengthening overseas operations: Over the past decade, the company has steadily established a presence in Europe, Southeast Asia, and the United States. Overseas business has maintained a good growth trend, gradually becoming a new engine for growth. The company’s understanding of international markets has become more comprehensive and in-depth. Currently, overseas revenue accounts for about 13%, with contribution steadily increasing. In recent years, the company has continuously explored global ophthalmology markets, engaging with multiple potential targets, which offers greater future opportunities. The company plans to build an international platform to enable resource sharing between domestic and overseas markets, promoting coordinated development of the overall business.

Empowering upgrades through advanced technology: The company highly values the application of cutting-edge new technologies in its operations. Going forward, it will strengthen integration, continuously promote technological, service, and scenario innovations, and provide comprehensive ophthalmic medical services across multiple levels and channels for all age groups. The company’s consistent approach is steady progress—looking ahead and choosing the right direction, while staying grounded to achieve long-term stability. As strategic goals are gradually realized, it is believed that operational performance will continue to improve.

(Source: Securities Daily)

Massive information, precise analysis, all on Sina Finance APP